Chantal Babb de Villiers

@chantalresearch.bsky.social

Researcher with a special interest in cancer, genetics, epidemiology and public health. Views are my own. Posts are not an endorsement.

The most recent validation of the PREDICT breast prognostic model published today (v3). doi.org/10.6004/jncc... Work in collaboration with Yi-Wen Hsiao, Pei-Chen Peng and Gordon Wishart. If any philanthropists out there want to cover to costs of maintaining this valuable clinical tool please DM me.

Assessing the Performance of the PREDICT Breast Version 3.0 Prognostic Tool in Patients With Breast Cancer in the United States

Background: PREDICT Breast version 3 (v3) is the latest updated prognostication tool, developed using data from approximately 35,000 women diagnosed with breast cancer between 2000 and 2018 in the Uni...

doi.org

The CONSORT and SPIRIT statements for randomized trials have been updated for 2025 and published in JAMA, with a new focus on open science principles and guidance on trial registration, data access, and conflict of interest reporting. ➡ CONSORT 2025: ja.ma/3Yyu0Hh ➡ SPIRIT 2025: ja.ma/3YjFfn8

👀 New blog👀 Health and climate change are inextricably linked, yet policy development tends to focus on one or the other. A joined up approach is necessary to create effective, sustainable improvements in environment-related health interventions. Read on... www.phgfoundation.org/blog/data-th...

Data: the catalyst for health and climate action  - PHG Foundation

Both health and climate change are highly complex issues,with numerous interdependencies. Integrating policy is challenging but essential.

phgfoundation.org

😍 We all love a one-page summary, so here's one for our strategic direction to accompany @peterfrmills.bsky.social blog. www.phgfoundation.org/blog/policy-... We're keen to hear the ambitions and views of others working at the science/health/policy interface, comments and DMs welcome.

A one page summary of PHG Foundation's five-year strategic direction and priority areas
Pete Mills@peterfrmills.bsky.social · last yr.

We've set out our strategic direction and priorities for 2025-30 in a new @phgfoundation.bsky.social publication. In a related post I describe where I think efforts to 'make science work for health' have brought us and what PHG's role can be: www.phgfoundation.org/blog/policy-...

Exciting News in Gene Therapy!  NICE has approved the use of gene therapy exa-cel for treating sickle cell disease! This groundbreaking development offers new hope for patients and marks a significant milestone in medical science. 🧬✨ www.phgfoundation.org/news/worlds-...

World’s first gene editing therapy now in the UK for sickle cell disease - PHG Foundation

The approval by NICE of Exa-cel provides new hope for people living with sickle cell disease.

phgfoundation.org